Home » Niklas Norgren

Niklas Norgren

UmanDiagnostics launches new product that can revolutionize research in neurological diseases

13
Oct

Swedish-based UmanDiagnostics, a Quanterix company, has developed a new type of product that makes it easier to detect neurological diseases. Called NF-light ™ serum ELISA, it was officially launched on October 12th and will now be sold worldwide.
“Our product can be used for research inthe field of neurological diseases throughout the world. It feels very exciting, because our product is clearly revolutionary”, says Niklas Norgren, VP, Managing Director and co-founder of UmanDiagnostics.

Read more

Recruitment drive at UmanDiagnostics continues as orders anticipated to rise

13
May

Last summer Umeå-based UmanDiagnostics was acquired by major US life science company Quanterix for $22.5 million. Now it is recruiting additional staff at its offices in Umeå to meet an expected rise in new orders.
“We’re continuing to invest and are confident we’ll come out of the Coronavirus crisis even stronger, despite the uncertainty being faced by many industries,” says Niklas Norgren, CEO of UmanDiagnostics.

Read more

​Three wins for life science at big business gala

11
Nov

When Umeå’s big business gala was held on November 7, three of twelve awards went to life science.
“Previously, life science had a relatively hidden role in Umeå – but during this year’s Umeågala we have proven that we are an industry that has great potential”, says Jennie Ekbeck, CEO of Umeå Biotech Incubator.

Read more

More jobs to Umandiagnostics – after USA buyout

30
Sep

Following the $22.5 million acquisition this summer of Umeå-based UmanDiagnostics by major US biotech company Quanterix more people are now being hired at its offices in Umeå.
“Demand for our products is extremely high in the global marketplace and we’re probably looking at hiring even more people in the future”, says Niklas Norgren, CEO of UmanDiagnostics.

Read more